Comparing the Ketogenic Effect of Coconut Oil and Different MCTs
NCT ID: NCT02679222
Last Updated: 2020-04-06
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2015-06-30
2017-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ketone Plasma Kinetics After Oral Intake Of Different MCT
NCT03603782
Ketone Plasma Kinetics After Oral Intake of Different Ketogenic Formulae
NCT05058157
Ketone Supplementation, Glycogen Replenishment and Time Trial Performance Following Glycogen Lowering Exercise
NCT04004676
Metabolomic Signature of Exogenous Ketosis
NCT05699707
Ketone Supplementation, Glucose Control, and Cardiovascular Function
NCT03817749
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Supplementation
Protocol involved seven separate but identical metabolic study days for each participant. the test substances were evaluated in random order: vehicle (Control) or 20 mL of the test oils (Coconut oil; tricaprin; tricaprylin; MCT \[tricaprylin/tricaprin\]; coconut oil + MCT \[50:50\]; Coconut oil + tricaprylin \[50:50\]) taken twice, once at breakfast and once at mid-day.
Coconut oil
20 g of coconut oil
Coconut oil + MCT
10 g of coconut oil + 10 g of MCT (60 of C8 + 40 of C10)
MCT
20 g of MCT (60 of C8+40 of C10)
Coconut oil + tricaprylin
10 g coconut oil + 10 g tricaprylin
Tricaprylin
20 g tricaprylin
Tricaprin
20 g tricaprin
Control
No supplement taken on this visit
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Coconut oil
20 g of coconut oil
Coconut oil + MCT
10 g of coconut oil + 10 g of MCT (60 of C8 + 40 of C10)
MCT
20 g of MCT (60 of C8+40 of C10)
Coconut oil + tricaprylin
10 g coconut oil + 10 g tricaprylin
Tricaprylin
20 g tricaprylin
Tricaprin
20 g tricaprin
Control
No supplement taken on this visit
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Smoking
* Clinically-significant gastro-intestinal disease/conditions.
* Clinically-significant liver disease/dysfunction.
* Clinically-significant cardiac disease/conditions.
* Clinically-significant abnormal coagulation.
* Taking a medication that could affect lipid and glucose metabolism
* Hypertension
* Pregnancy or breastfeeding
* Exercising more than 3 times a week
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université de Sherbrooke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen Cunnane, PhD
Role: PRINCIPAL_INVESTIGATOR
CSSS-IUGS - CIUSSS de L'Estrie - CHUS - Université de Sherbrooke
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Centre on Aging (CSSS-IUGS - CIUSSS de l'Estrie - CHUS)
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-541
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.